TCD_20_C0394 - Antibody testing of human plasma samples using VirScan Technology
This Voluntary ex ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to issue a contract to CDI Laboratories. This will activate laboratory based analysis services using the proprietary VirScan™ technology. The VirScan™ technology offers unique sample throughput capability and is critical to the objectives of the research programme funded by SFI at Trinity College Dublin.
Services
08/12/2020 14:00:00
85111810-1 Blood analysis services
33696200-7 Blood-testing reagents
71600000-4 Technical testing, analysis and consultancy services
73111000-3 Research laboratory services
Trinity College Dublin, the University of Dublin
College Green
Co. Dublin
Dublin 2
Ireland
View profile
Kevin Ryan
http://www.tcd.ie
| Notice | Date of dispatch |
|---|---|
| Contract award notice (TED (v209)) | 09/12/2020 16:41 |
This Voluntary ex ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to issue a contract to CDI Laboratories. This will activate laboratory based analysis services using the proprietary VirScan™ technology. The VirScan™ technology offers unique sample throughput capability and is critical to the objectives of the research programme funded by SFI at Trinity College Dublin.